ORGANIGRAM Corporate Presentation

4 • Fiscal 2019 Financial Results NET REVENUE GROSS MARGIN before FV CHANGES to BIO ASSETS & INVENTORIES POSITIVE ADJUSTED EBITDA² NET INCOME (LOSS)4 2019 net revenue grew over 6 times or 547% from 2018 on the legalization of adult-use recreational cannabis in Canada Gross margin before fair value changes to bio assets and inventory increased 575% to 47% from 2018 2019 positive adjusted EBITDA margin² of 25% as a percentage of net revenue 2019 SG&A³ at 41% of net revenue 2019 net loss of $9.5M or $0.07 per share (fully diluted) largely due to fair value changes to bio assets and inventory ($M) ($M and %) ($M) 47% ($M) 37.9 80.4 22.1 45% 19.9 (1.0) 12.4 5.6 (9.5) FY-2018 FY-2019 FY-2018 FY-2019 FY-2018 1 Based on the Company's analysis of available data including, but not limited to, market share data from select provinces and various public data 2 Adjusted EBITDA is a non-IFRS measures with no standardized meaning under IFRS. See Company's Q4 2019 MD&A. 234 Sales & Marketing and General & Administrative excluding share-based compensation From continuing operations FY-2019 FY-2018 FY-2019 ORGANIGRAM

View entire presentation